Literature DB >> 2793229

Cytogenetic abnormalities in human ependymomas.

M R Stratton1, J Darling, P L Lantos, C S Cooper, B R Reeves.   

Abstract

The karyotypes of 4 human ependymomas have been determined. In one ependymoma, translocations involving chromosomes 9, 17 and 22 were observed together with the loss of the normal chromosome 17. A second ependymoma had many chromosomal alterations that included a translocation between chromosomes 1 and 2 and re-arrangements involving chromosome 17. No major consistent alterations were detected in the remaining 2 cases. Our karyotypes do not resemble the few previously published karyotypes of ependymomas, but had features, such as the alterations involving chromosome 17, that were similar to those of other brain tumours in children.

Entities:  

Mesh:

Year:  1989        PMID: 2793229     DOI: 10.1002/ijc.2910440403

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Infrequency of p53 gene mutations in ependymomas.

Authors:  K L Fink; E J Rushing; S C Schold; P D Nisen
Journal:  J Neurooncol       Date:  1996-02       Impact factor: 4.130

2.  Recurrent anaplastic ependymoma with an abnormal karyotype and c-myc proto-oncogene overexpression.

Authors:  M Debiec-Rychter; J Lasota; J Alwasiak; P P Liberski
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 3.  Molecular pathogenesis of childhood brain tumors.

Authors:  Torsten Pietsch; Michael D Taylor; James T Rutka
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

4.  Molecular cytogenetic studies of pediatric ependymomas.

Authors:  D L Kramer; A H Parmiter; L B Rorke; L N Sutton; J A Biegel
Journal:  J Neurooncol       Date:  1998-03       Impact factor: 4.130

Review 5.  Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective.

Authors:  Judith M de Bont; Roger J Packer; Erna M Michiels; Monique L den Boer; Rob Pieters
Journal:  Neuro Oncol       Date:  2008-08-01       Impact factor: 12.300

6.  p53 protein expression in central nervous system tumors: an immunohistochemical study with CM1 polyvalent and DO-7 monoclonal antibodies.

Authors:  E Karamitopoulou; E Perentes; I Diamantis
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

Review 7.  Molecular biology of pediatric gliomas.

Authors:  C Raffel
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

Review 8.  The genetic and epigenetic basis of ependymoma.

Authors:  Stephen C Mack; Michael D Taylor
Journal:  Childs Nerv Syst       Date:  2009-06-18       Impact factor: 1.475

9.  Genetic abnormalities detected in ependymomas by comparative genomic hybridisation.

Authors:  M Carter; J Nicholson; F Ross; J Crolla; R Allibone; V Balaji; R Perry; D Walker; R Gilbertson; D W Ellison
Journal:  Br J Cancer       Date:  2002-03-18       Impact factor: 7.640

10.  Genome-wide analysis of subependymomas shows underlying chromosomal copy number changes involving chromosomes 6, 7, 8 and 14 in a proportion of cases.

Authors:  Kathreena M Kurian; David T W Jones; Faye Marsden; Sam W S Openshaw; Danita M Pearson; Koichi Ichimura; V Peter Collins
Journal:  Brain Pathol       Date:  2008-04-07       Impact factor: 6.508

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.